跳至主要内容
临床试验/CTRI/2025/02/081352
CTRI/2025/02/081352尚未招募2/3 期

Efficacy of MTA and Recombinant human platelet derived growth factor(rh PDGF- BB) as pulp treatment agents - A randomized controlled trial.

Dr ANITHA T1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2025年3月20日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
24
试验地点
1
主要终点
clinical success( no subjective symptoms,no top,mobility,no swelling)

研究概览

简要总结

This study is mainly planned to compare the efficacy of recombinant platelet derived growth factor as pulp capping agent with MTA in dentin bridge formation

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Class 1 caries in maxillary and mandibular first and second molar with deep caries.
  • Radiographs showing caries approximating pulp will be included.
  • Asymptomatic patients with no tenderness to percussion, positive response to electric pulp testing, and cold test.
  • Normal periodontal status clinically and radiographically will be included.

排除标准

  • Patients with any Systemic disease will be excluded.
  • History of spontaneous and nocturnal pain.
  • Teeth showing negative response to electric pulp testing and cold test.
  • Teeth with radiographic evidence of pulpal degeneration, resorption, and periapical changes.

结局指标

主要结局

clinical success( no subjective symptoms,no top,mobility,no swelling)

时间窗: 6th month

Radiographic success- absence of pulpal and periapical pathologies

时间窗: 6th month

次要结局

  • Presence or absence of dentin bridge formation & volume of formed dentin bridge in cubic mm(6th month)

研究者

发起方
Dr ANITHA T
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr ANITHA T

KSR Institute of Dental Science and Research,Tiruchengode.

研究点 (1)

Loading locations...

相似试验